Yi Yao

Yi Yao

Auto-generated profile, based on publicly available information

Yi Yao

Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA; Center for Cutaneous Biology and Immunology, Henry Ford Health System, Detroit, Michigan, USA; Immunology Research Program, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
YYYi Yao
Yi Yao
HMHironori Matsushima
Hironori Matsushima
JOJennifer A Ohtola
Jennifer A Ohtola
SGShuo Geng
Shuo Geng
RLRan Lu
Ran Lu
ATAkira Takashima
Akira Takashima
Rapid enhancement of phagocyte functionality is a hallmark of neutrophil priming. GeneChip analyses unveiled elevated CD54, dectin-2, and IL-1β mRNA expression by neutrophils isolated from inflammatory sites. In fact, CD54 and dectin-2 protein expression was detected on neutrophils recovered from skin, peritoneal, and lung inflammation lesions but not on those in bone marrow or peripheral blood. Neutrophils increased CD54 and dectin-2 mRNA during migration in Boyden chambers and acquired CD54 and dectin-2 surface expression after subsequent exposure to GM-CSF. Neutrophils purified from IL-1β promoter-driven DsRed-transgenic mice acquired DsRed signals during cell migration or exposure to GM-CSF. CD54 and dectin-2 were expressed by DsRed+ (but not DsRed−) neutrophils in GM-CSF–supplemented cultures, and neutrophils recovered from inflammatory sites exhibited strong DsRed signals. The dynamic process of neutrophil priming was studied in chemically induced inflammatory skin lesions by monitoring DsRed expression using confocal microscopy. A majority (>80%) of Ly6G+ neutrophils expressed DsRed, and those DsRed+/Ly6G+ cells exhibited crawling motion with a higher velocity compared with their DsRed−/Ly6G+ counterparts. This report unveils motile behaviors of primed neutrophils in living animals. We propose that neutrophil priming occurs in a sequential manner with rapid enhancement of phagocyte functionality, followed by CD54 and dectin-2 mRNA and protein expression, IL-1β promoter activation, and accelerated motility. Not only do these findings provide a new conceptual framework for our understanding of the process of neutrophil priming, they also unveil new insights into the pathophysiology of many inflammatory disorders that are characterized by neutrophil infiltration.

1 April 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JVJesse Veenstra
Jesse Veenstra
PDPeter Dimitrion
Peter Dimitrion
YYYi Yao
Yi Yao
LZLi Zhou
Li Zhou
DODavid Matthew Ozog
David Matthew Ozog
QMQing-Sheng Mi
Qing-Sheng Mi

3 April 2023
Verified
Other
Open access
GRGarrett W. Rhyasen
Garrett W. Rhyasen
MHMaureen M. Hattersley
Maureen M. Hattersley
YYYi Yao
Yi Yao
ADAustin Dulak
Austin Dulak
WWWenxian Wang
Wenxian Wang
HCHuawei Chen
Huawei Chen

3 April 2023
Verified
Other
Open access
GRGarrett W. Rhyasen
Garrett W. Rhyasen
MHMaureen M. Hattersley
Maureen M. Hattersley
YYYi Yao
Yi Yao
ADAustin Dulak
Austin Dulak
WWWenxian Wang
Wenxian Wang
HCHuawei Chen
Huawei Chen
Protein modulation by AZD5153 in hematological cell lines

3 April 2023
Verified
Other
Open access
GRGarrett W. Rhyasen
Garrett W. Rhyasen
MHMaureen M. Hattersley
Maureen M. Hattersley
YYYi Yao
Yi Yao
ADAustin Dulak
Austin Dulak
WWWenxian Wang
Wenxian Wang
HCHuawei Chen
Huawei Chen

3 April 2023
Verified
Other
Open access
GRGarrett W. Rhyasen
Garrett W. Rhyasen
MHMaureen M. Hattersley
Maureen M. Hattersley
YYYi Yao
Yi Yao
ADAustin Dulak
Austin Dulak
WWWenxian Wang
Wenxian Wang
HCHuawei Chen
Huawei Chen
Supplementary Figure 1. AZD5153 shows reduced BRD4 binding activity when BD2 function is abolished; Supplementary Figure 2. AZD5153 modulates MYC protein levels across hematologic cancer cell lines; Supplementary Figure 3. Gene Ontology (GO) analysis of the down-regulated transcripts by AZD5153 across all cell line types; Supplementary Figure 4. IC50 and percent maximal cell kill by AZD5153 and I-BET762 in five hematologic cell lines; Supplementary Figure 5. Tumor growth inhibition across six hematological xenograft Models